Transaction · 0000874015-26-000112

BENNETT C FRANK

BENNETT C FRANK, EVP, CSO, reported a transaction classified as other at IONIS PHARMACEUTICALS INC involving 0.000000 shares for an estimated $0.00. Reported holdings after the transaction were 100293.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

otherSEC transaction code JEVP, CSO
IONSIONIS PHARMACEUTICALS INC
Filing timeFeb 13
Trade dateFeb 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$80.59
Pre-filing
1mo ago -1.1%1w ago +0.5%1d ago +2.6%
Returns since
7d +3.2%30d -11.7%90d -6.1%180d -29.9%1y -20.7%

IONS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IONS since 2026-02-13Filed 202 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
other
Code J
Identifier
0000874015-26-000112
Common Stock
Transaction date
Feb 02, 2026
Filed Feb 13, 2026, 12:00 AM · 11d delay
Shares
0 sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
100k sh
Direct

Filing warnings

Notes recorded with this filing
3 warnings
amended filingThis transaction comes from an amended Form 4 filing.
delayed filingThe filing was reported 11 calendar days after the transaction date.
ambiguous transaction codeThe transaction code is missing or represents other activity; review the filing and footnotes.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Amended Filing Delayed Filing Direct Ownership
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Chief Scientific Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    On February 4, 2026, the reporting person filed a Form 4 reporting the sale of 20,000 shares of common stock and the exercise of 65,089 stock options, which transactions were executed in error and sub…

Amended filing · 0000874015-26-000112
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IONS